Yang L, Liu Y, Wang C, Feng Z, Yu L, Pan J
Neoplasia. 2024; 57:101060.
PMID: 39357265
PMC: 11474188.
DOI: 10.1016/j.neo.2024.101060.
Schroeder L, Kritselis M, Lala N, Boxerman J, Alhusaini S
Neurology. 2023; 101(21):974-978.
PMID: 37788936
PMC: 10663027.
DOI: 10.1212/WNL.0000000000207857.
Serbis A, Tsinopoulou V, Papadopoulou A, Kolanis S, Sakellari E, Margaritis K
Diagnostics (Basel). 2023; 13(9).
PMID: 37174978
PMC: 10177772.
DOI: 10.3390/diagnostics13091588.
Teng Y, Ran X, Chen B, Chen C, Xu J
J Clin Med. 2022; 11(24).
PMID: 36556097
PMC: 9782822.
DOI: 10.3390/jcm11247481.
Wu J, Wu X, Yang Y, Ding H, Yang L, Bao Y
Neurosurg Rev. 2021; 45(1):139-150.
PMID: 34159471
DOI: 10.1007/s10143-021-01563-9.
Clinicopathological Features of Craniopharyngioma: A 15-Year Study From a Tertiary Care Center in Pakistan.
Haroon S, Afzal A, Zia S, Ali S, Zia F, Shamail F
Cureus. 2021; 13(3):e14153.
PMID: 33936868
PMC: 8076872.
DOI: 10.7759/cureus.14153.
Diagnosis and Management of pituitary disease with focus on the role of Magnetic Resonance Imaging.
Mahajan A, Bronen R, Mian A, Omay S, Spencer D, Inzucchi S
Endocrine. 2020; 68(3):489-501.
PMID: 32162185
DOI: 10.1007/s12020-020-02242-3.
Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma.
Khatami F, Larijani B, Heshmat R, Nasiri S, Saffar H, Shafiee G
Iran J Pathol. 2019; 14(4):290-298.
PMID: 31754358
PMC: 6824767.
DOI: 10.30699/ijp.2019.94401.1922.
Personalized treatment options for thyroid cancer: current perspectives.
Khatami F, Larijani B, Nikfar S, Hasanzad M, Fendereski K, Tavangar S
Pharmgenomics Pers Med. 2019; 12:235-245.
PMID: 31571972
PMC: 6750856.
DOI: 10.2147/PGPM.S181520.
Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy.
Khatami F, Tavangar S
J Diabetes Metab Disord. 2018; 17(1):19-30.
PMID: 30288382
PMC: 6154523.
DOI: 10.1007/s40200-018-0334-x.
Radical Resection of Craniopharyngioma: Discussions Based on Long-term Clinical Course and Histopathology of the Dissection Plane.
Okada T, Fujitsu K, Ichikawa T, Miyahara K, Tanino S, Uriu Y
Asian J Neurosurg. 2018; 13(3):640-646.
PMID: 30283518
PMC: 6159031.
DOI: 10.4103/ajns.AJNS_258_16.
Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives.
Khatami F, Tavangar S
Biomark Insights. 2018; 13:1177271918785129.
PMID: 30013307
PMC: 6043927.
DOI: 10.1177/1177271918785129.
Clear Cell Sarcoma: A Case Report and Review of Literature.
Abdollahi A, Khatami F, Tavangar S
Int J Hematol Oncol Stem Cell Res. 2018; 12(1):65-68.
PMID: 29951180
PMC: 6018246.
Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review.
Coury J, Davis B, Koumas C, Manzano G, Dehdashti A
Neurosurg Rev. 2018; 43(1):41-48.
PMID: 29666970
DOI: 10.1007/s10143-018-0978-5.
Current Diagnostic Status of Pheochromocytomaand Future Perspective: A Mini Review.
Khatami F, Tavangar S
Iran J Pathol. 2018; 12(3):313-322.
PMID: 29531562
PMC: 5835385.
Genetic and Epigenetic of Medullary Thyroid Cancer.
Khatami F, Tavangar S
Iran Biomed J. 2017; 22(3):142-50.
PMID: 29126344
PMC: 5889499.
DOI: 10.22034/ibj.22.3.142.
Comprehensive analysis of Iranian reports of pediatric central nervous system tumors.
Mehrvar N, Mehrvar A, Akbari M, Qaddoumi I
Childs Nerv Syst. 2017; 33(9):1481-1490.
PMID: 28555309
PMC: 5708155.
DOI: 10.1007/s00381-017-3468-0.
Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.
Malgulwar P, Nambirajan A, Pathak P, Faruq M, Suri V, Sarkar C
J Neurooncol. 2017; 133(3):487-495.
PMID: 28500561
DOI: 10.1007/s11060-017-2465-1.
Craniopharyngiomas : Radiological Differentiation of Two Types.
Lee I, Zan E, Bell W, Burger P, Sung H, Yousem D
J Korean Neurosurg Soc. 2016; 59(5):466-70.
PMID: 27651864
PMC: 5028606.
DOI: 10.3340/jkns.2016.59.5.466.
Craniopharyngioma: Survivin expression and ultrastructure.
Zhu J, You C
Oncol Lett. 2014; 9(1):75-80.
PMID: 25435936
PMC: 4246612.
DOI: 10.3892/ol.2014.2690.